Your browser doesn't support javascript.
loading
Establishing 20S Proteasome Genetic, Translational and Post-Translational Status from Precious Biological and Patient Samples with Top-Down MS.
Dafun, Angelique Sanchez; Zivkovic, Dusan; Leon-Icaza, Stephen Adonai; Möller, Sophie; Froment, Carine; Bonnet, Delphine; de Jesus, Adriana Almeida; Alric, Laurent; Quaranta-Nicaise, Muriel; Ferrand, Audrey; Cougoule, Céline; Meunier, Etienne; Burlet-Schiltz, Odile; Ebstein, Frédéric; Goldbach-Mansky, Raphaela; Krüger, Elke; Bousquet, Marie-Pierre; Marcoux, Julien.
Afiliación
  • Dafun AS; Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS, Université Toulouse III-Paul Sabatier (UPS), 31077 Toulouse, France.
  • Zivkovic D; Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS, Université Toulouse III-Paul Sabatier (UPS), 31077 Toulouse, France.
  • Leon-Icaza SA; Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS, Université Toulouse III-Paul Sabatier (UPS), 31077 Toulouse, France.
  • Möller S; Institute of Medical Biochemistry and Molecular Biology, University Medicine Greifswald, 17475 Greifswald, Germany.
  • Froment C; Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS, Université Toulouse III-Paul Sabatier (UPS), 31077 Toulouse, France.
  • Bonnet D; IRSD, Université de Toulouse, INSERM, INRAE, ENVT, Université de Toulouse III-Paul Sabatier (UPS), 31300 Toulouse, France.
  • de Jesus AA; Internal Medicine Department of Digestive Disease, Rangueil Hospital, Université de Toulouse III-Paul Sabatier (UPS), 31400 Toulouse, France.
  • Alric L; Translational Autoinflammatory Diseases Section, LCIM, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Quaranta-Nicaise M; Internal Medicine Department of Digestive Disease, Rangueil Hospital, Université de Toulouse III-Paul Sabatier (UPS), 31400 Toulouse, France.
  • Ferrand A; IRSD, Université de Toulouse, INSERM, INRAE, ENVT, Université de Toulouse III-Paul Sabatier (UPS), 31300 Toulouse, France.
  • Cougoule C; IRSD, Université de Toulouse, INSERM, INRAE, ENVT, Université de Toulouse III-Paul Sabatier (UPS), 31300 Toulouse, France.
  • Meunier E; Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS, Université Toulouse III-Paul Sabatier (UPS), 31077 Toulouse, France.
  • Burlet-Schiltz O; Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS, Université Toulouse III-Paul Sabatier (UPS), 31077 Toulouse, France.
  • Ebstein F; Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS, Université Toulouse III-Paul Sabatier (UPS), 31077 Toulouse, France.
  • Goldbach-Mansky R; Institute of Medical Biochemistry and Molecular Biology, University Medicine Greifswald, 17475 Greifswald, Germany.
  • Krüger E; Translational Autoinflammatory Diseases Section, LCIM, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Bousquet MP; Institute of Medical Biochemistry and Molecular Biology, University Medicine Greifswald, 17475 Greifswald, Germany.
  • Marcoux J; Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS, Université Toulouse III-Paul Sabatier (UPS), 31077 Toulouse, France.
Cells ; 12(6)2023 03 08.
Article en En | MEDLINE | ID: mdl-36980185
The mammalian 20S catalytic core of the proteasome is made of 14 different subunits (α1-7 and ß1-7) but exists as different subtypes depending on the cell type. In immune cells, for instance, constitutive catalytic proteasome subunits can be replaced by the so-called immuno-catalytic subunits, giving rise to the immunoproteasome. Proteasome activity is also altered by post-translational modifications (PTMs) and by genetic variants. Immunochemical methods are commonly used to investigate these PTMs whereby protein-tagging is necessary to monitor their effect on 20S assembly. Here, we present a new miniaturized workflow combining top-down and bottom-up mass spectrometry of immunopurified 20S proteasomes that analyze the proteasome assembly status as well as the full proteoform footprint, revealing PTMs, mutations, single nucleotide polymorphisms (SNPs) and induction of immune-subunits in different biological samples, including organoids, biopsies and B-lymphoblastoid cell lines derived from patients with proteasome-associated autoinflammatory syndromes (PRAAS). We emphasize the benefits of using top-down mass spectrometry in preserving the endogenous conformation of protein modifications, while enabling a rapid turnaround (1 h run) and ensuring high sensitivity (1-2 pmol) and demonstrate its capacity to semi-quantify constitutive and immune proteasome subunits.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Procesamiento Proteico-Postraduccional / Complejo de la Endopetidasa Proteasomal Límite: Animals / Humans Idioma: En Revista: Cells Año: 2023 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Procesamiento Proteico-Postraduccional / Complejo de la Endopetidasa Proteasomal Límite: Animals / Humans Idioma: En Revista: Cells Año: 2023 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Suiza